65 related articles for article (PubMed ID: 19663652)
21. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
22. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
[TBL] [Abstract][Full Text] [Related]
23. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
24. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
25. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
26. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
[TBL] [Abstract][Full Text] [Related]
27. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
28. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis.
Han SJ; Kang ES; Hur KY; Kim HJ; Kim SH; Yun CO; Choi SE; Ahn CW; Cha BS; Kang Y; Lee HC
Horm Res; 2008; 70(3):165-73. PubMed ID: 18663317
[TBL] [Abstract][Full Text] [Related]
30. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
Moyers JS; Shiyanova TL; Mehrbod F; Dunbar JD; Noblitt TW; Otto KA; Reifel-Miller A; Kharitonenkov A
J Cell Physiol; 2007 Jan; 210(1):1-6. PubMed ID: 17063460
[TBL] [Abstract][Full Text] [Related]
32. Relationship between peroxisome proliferator-activated receptor-gamma activation and the ameliorative effects of ascochlorin derivatives on type II diabetes.
Magae J; Tsuruga M; Maruyama A; Furukawa C; Kojima S; Shimizu H; Ando K
J Antibiot (Tokyo); 2009 Jul; 62(7):365-9. PubMed ID: 19557028
[TBL] [Abstract][Full Text] [Related]
33. Two thiophenes compounds are partial peroxisome proliferator-activated receptor α/γ dual agonists.
Zheng Z; Yang Y; Shao H; Liu Z; Lu X; Xu Y; He X; Jiang W; Jiang Q; Zhao B; Zhang H; Li Z; Si S
Biol Pharm Bull; 2011; 34(10):1631-4. PubMed ID: 21963508
[TBL] [Abstract][Full Text] [Related]
34. Mechanism for antioxidative effects of thiazolidinediones in pancreatic β-cells.
Chung SS; Kim M; Lee JS; Ahn BY; Jung HS; Lee HM; Park KS
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E912-21. PubMed ID: 21846907
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.
Maganti AV; Tersey SA; Syed F; Nelson JB; Colvin SC; Maier B; Mirmira RG
J Biol Chem; 2016 Oct; 291(43):22524-22533. PubMed ID: 27613867
[TBL] [Abstract][Full Text] [Related]
36. Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.
Davoodi-Semiromi A; Wasserfall CH; Hassanzadeh A; Cooper-DeHoff RM; Wabitsch M; Atkinson M
Immunogenetics; 2013 Jan; 65(1):83-90. PubMed ID: 23081744
[TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.
Welters HJ; El Ouaamari A; Kawamori D; Meyer J; Hu J; Smith DM; Kulkarni RN
Endocrinology; 2012 Oct; 153(10):4593-9. PubMed ID: 22807489
[TBL] [Abstract][Full Text] [Related]
38. Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms.
Wang AP; Li X; Zheng Y; Liu BL; Huang G; Yan X; Liu Z; Zhou Z
Acta Diabetol; 2013 Apr; 50(2):163-73. PubMed ID: 21153483
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers.
Huiying Z; Guangying C; Shiyang Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):981-989. PubMed ID: 31072232
[TBL] [Abstract][Full Text] [Related]
40. Petalonia improves glucose homeostasis in streptozotocin-induced diabetic mice.
Kang SI; Jin YJ; Ko HC; Choi SY; Hwang JH; Whang I; Kim MH; Shin HS; Jeong HB; Kim SJ
Biochem Biophys Res Commun; 2008 Aug; 373(2):265-9. PubMed ID: 18555794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
